Seller record · Telehealth service

Alloy

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the product pages or in the policies.

At a glance

AlloyTelehealth service

7/8criteria passed

Price: Compounded semaglutide from $70, plus $99 a month Weight Care fee
Sells: compounded semaglutide, compounded tirzepatide, compounded liraglutide, and 3 more
FDA letters: None on file

Visit Alloy See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A menopause telehealth service that also sells compounded semaglutide, tirzepatide and liraglutide and brand Wegovy and Zepbound through a weight care program with a monthly fee. It names three filling pharmacies with street addresses in its terms.

Operating entity Alloy Health, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Alloy's website; Alloy's terms of use page
S2	Prescription gating	PASS	Alloy's relief type page on its secure site
S3	Pharmacy identification	PASS	Alloy's terms of use page
S4	Compounding disclosure	PASS	Alloy's website
S5	Analytical documentation	FAIL	Alloy's website
S6	Business address	PASS	Alloy's terms of use page; Alloy's privacy policy
S7	Price disclosure	PASS	Alloy's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA physician reviews the buyer's symptoms and history and decides whether compounded semaglutide fits, and the terms say no prescription product is available without a consultation with one of its providers.Source: Alloy's website; Alloy's terms of use page.

S2PASSThe start button opens an intake whose first screen asks what brings the buyer to Alloy.Source: Alloy's relief type page on its secure site.

S3PASSThe terms name three pharmacies with street addresses: Curexa Pharmacy in Egg Harbor Township, New Jersey, BLEND Pharmacy in Columbus, Ohio, and Gogo Pharmacy in Southgate, Kentucky.FDA warning letter 663403 is addressed to Curexa – East, LLC dba Curexa, a pharmacy named here.Source: Alloy's terms of use page.

S4PASSThe product pages state that compounded medications, unlike FDA-approved drugs, are not reviewed by FDA for safety, effectiveness or quality.Source: Alloy's website.

S5FAILNo certificate of analysis or lot document is published on the product pages or in the policies.Source: Alloy's website.

S6PASSAlloy Health, Inc. at 99 Wall Street #2031, New York, NY 10005, printed in the terms and the privacy policy.Source: Alloy's terms of use page; Alloy's privacy policy.

S7PASSCompounded semaglutide from $70, compounded tirzepatide from $100 and compounded liraglutide from $115 for a one-month supply, plus the Alloy Weight Care fee of $99 a month. Zepbound from $299.Source: Alloy's website.

S8PASSNo FDA warning letter names Alloy or Alloy Health, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded liraglutide, brand Wegovy pen and pill, brand Zepbound, estradiol.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells liraglutide

A warning letter to a pharmacy this seller names

FDA warning letter 663403, issued September 2023, to Curexa – East, LLC dba Curexa“During the inspection, the investigators noted serious deficiencies in your practices for producing drug products, which put patients at risk.”

The letter is addressed to the pharmacy, not to Alloy, and changes no disposition on this record.

Unpaid link. Alloy does not pay the site, and nothing is earned when it is used. Funding.

Visit Alloy

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.